RecallDepth
Class II Ongoing

Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88

This recall is currently active, issued July 23, 2025. It was issued by Sun Pharmaceutical Industries Inc.

Company
Sun Pharmaceutical Industries Inc
Recall Initiated
June 16, 2025
Posted
July 23, 2025
Recall Number
D-0516-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
5,448 bottles
Firm Location
Princeton, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).

Distribution

Recalled units were distributed to 17 distributors who may have further distributed the product nationwide.

Lot / Code Info

Lot # AD42648, Exp 02/28/2026

More recalls by Sun Pharmaceutical Industries Inc

View all recalls by this company →

Other recent Class II Drug recalls